Depending on one’s perspective, the anti-inflammatory colchicine is either an unsung and underprescribed drug for patients with cardiovascular disease, or it’s an agent with limited clinical benefit ...
The drug colchicine may reduce cardiovascular outcomes among patients with gout, based on a range of retrospective data that suggest improved outcomes and mechanistic connections between gout and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback